Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Filter
  • 1-22 of  22 results for ""Hematopoietic Stem Cell Transplantation""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Reduced intensity conditioning for hematopoietic stem cell transplantation: has it achieved all it set out to?

  • Authors : Turner BE; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.; Collin M

Subjects: Hematopoietic Stem Cell Transplantation* ; Transplantation Conditioning*; Graft vs Host Disease/Graft vs Host Disease/Graft vs Host Disease/*etiology

  • Source: Cytotherapy [Cytotherapy] 2010 Jul; Vol. 12 (4), pp. 440-54.Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print Cited Medium: Internet

Record details

×
Editorial & Opinion

Intra-bone route of administration offers new perspectives for safer transplantation of hematopoietic stem cells.

  • Authors : Frassoni F; Stem Cell and Cell Therapy Centre, Ospedale San Martino, Genova, Italy.

Subjects: Bone and Bones/Bone and Bones/Bone and Bones/*surgery ; Graft Rejection/Graft Rejection/Graft Rejection/*prevention & control ; Graft vs Host Disease/Graft vs Host Disease/Graft vs Host Disease/*prevention & control

  • Source: Cytotherapy [Cytotherapy] 2010; Vol. 12 (1), pp. 5-6.Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Immune-mediated attack in relapsed Hodgkin's lymphoma.

  • Authors : Corradini P; Department of Haematology, Istituto Nazionale per lo Studio e la Cura dei Tumori, University of Milano, Milano, Italy. ; Farina L

Subjects: Hematopoietic Stem Cell Transplantation*; Graft vs Host Disease/Graft vs Host Disease/Graft vs Host Disease/*immunology ; Hodgkin Disease/Hodgkin Disease/Hodgkin Disease/*immunology

  • Source: Lancet (London, England) [Lancet] 2005 Jun 4-10; Vol. 365 (9475), pp. 1906-8.Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation.

  • Authors : Peggs KS; Department of Haematology, Royal Free and University College London, UK. ; Hunter A

Subjects: Hematopoietic Stem Cell Transplantation*; Graft vs Host Disease/Graft vs Host Disease/Graft vs Host Disease/*immunology ; Hodgkin Disease/Hodgkin Disease/Hodgkin Disease/*immunology

  • Source: Lancet (London, England) [Lancet] 2005 Jun 4-10; Vol. 365 (9475), pp. 1934-41.Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Modulation of GvHD by suicide-gene transduced donor T lymphocytes: clinical applications in mismatched transplantation.

  • Authors : Ciceri F; Hematology and Cancer Immune Therapy and Gene Therapy Program, San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milan, Italy.; Bonini C

Subjects: Genes, Transgenic, Suicide* ; Hematopoietic Stem Cell Transplantation*; Genetic Therapy/Genetic Therapy/Genetic Therapy/*methods

  • Source: Cytotherapy [Cytotherapy] 2005; Vol. 7 (2), pp. 144-9.Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

Improving the ex vivo retroviral-mediated suicide-gene transfer process in T lymphocytes to preserve immune function.

  • Authors : Robinet E; INSERM U645-UPRES EA2284, EFS Bourgogne/Franche-Comté, 1 boulevard A. Fleming, IFR 133, 25020 Besançon Cedex, France.; Fehse B

Subjects: Gene Transfer Techniques* ; Genes, Transgenic, Suicide*/Genes, Transgenic, Suicide*/Genes, Transgenic, Suicide*/genetics ; Hematopoietic Stem Cell Transplantation*

  • Source: Cytotherapy [Cytotherapy] 2005; Vol. 7 (2), pp. 150-7.Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

Therapeutic potential of CD4+ CD25+ regulatory T cells in allogeneic transplantation.

  • Authors : Cohen JL; Biologie et Thérapeutique des Pathologies Immunitaires, CNRS/UPMC UMR 7087, Hôpital Pitié-Salpêtrière, 83 boulevard de l'Hôpital, F-75651 Paris Cedex 13, France.; Salomon BL

Subjects: Hematopoietic Stem Cell Transplantation* ; Organ Transplantation*; CD4-Positive T-Lymphocytes/CD4-Positive T-Lymphocytes/CD4-Positive T-Lymphocytes/*immunology

  • Source: Cytotherapy [Cytotherapy] 2005; Vol. 7 (2), pp. 166-70.Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

Selective depletion strategies in allogeneic stem cell transplantation.

  • Authors : Mielke S; Stem Cell Allogeneic Transplantation Section, National Heart, Lung & Blood Institute/NIH, Bldg. 10 CRC Room 3-5288, 10 Center Drive, Bethesda, MD 20892, USA.; Solomon SR

Subjects: Hematopoietic Stem Cell Transplantation* ; T-Lymphocytes*/T-Lymphocytes*/T-Lymphocytes*/immunology; Graft vs Host Disease/Graft vs Host Disease/Graft vs Host Disease/*prevention & control

  • Source: Cytotherapy [Cytotherapy] 2005; Vol. 7 (2), pp. 109-15.Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

Selective allodepletion.

Subjects: Hematopoietic Stem Cell Transplantation* ; Lymphocyte Depletion*/Lymphocyte Depletion*/Lymphocyte Depletion*/methods ; T-Lymphocytes*

  • Source: Cytotherapy [Cytotherapy] 2005; Vol. 7 (2), pp. 101.Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

Improving immune reconstitution while preventing GvHD in allogeneic stem cell transplantation.

  • Authors : André-Schmutz I; INSERM U429 and Biotherapy Department, Division of Pediatric Immunology and Haematology, Necker Hospital for Sick Children, 149 rue de Sevres, 75743 Paris Cedex 15, France.; Dal Cortivo L

Subjects: Hematopoietic Stem Cell Transplantation* ; Lymphocyte Transfusion*/Lymphocyte Transfusion*/Lymphocyte Transfusion*/methods; Graft vs Host Disease/Graft vs Host Disease/Graft vs Host Disease/*prevention & control

  • Source: Cytotherapy [Cytotherapy] 2005; Vol. 7 (2), pp. 102-8.Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation: a phase 1/2 study.

  • Authors : André-Schmutz I; Laboratoire de Thérapie Cellulaire et Génique, INSERM U 429, Hôpital Necker Enfants Malades, Paris, France.; Le Deist F

Subjects: Hematopoietic Stem Cell Transplantation*; Graft vs Host Disease/Graft vs Host Disease/Graft vs Host Disease/*prevention & control ; Hematologic Neoplasms/Hematologic Neoplasms/Hematologic Neoplasms/*therapy

  • Source: Lancet (London, England) [Lancet] 2002 Jul 13; Vol. 360 (9327), pp. 130-7.Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease.

  • Authors : Biedermann BC; Department of Medicine, University Hospital Bruderholz, Bruderholz, Switzerland. ; Sahner S

Subjects: Hematopoietic Stem Cell Transplantation*; Endothelium, Vascular/Endothelium, Vascular/Endothelium, Vascular/*pathology ; Graft vs Host Disease/Graft vs Host Disease/Graft vs Host Disease/*pathology

  • Source: Lancet (London, England) [Lancet] 2002 Jun 15; Vol. 359 (9323), pp. 2078-83.Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

Infectious complications following T-cell depleted hematopoietic stem-cell transplantation.

  • Authors : Novitzky N; The University of Cape Town Leukaemia Centre, Department of Haematology, Groote Schuur Hospital, Cape Town, South Africa.; Rouskova A

Subjects: Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*adverse effects ; Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*therapeutic use ; Bone Marrow Transplantation/Bone Marrow Transplantation/Bone Marrow Transplantation/*adverse effects

  • Source: Cytotherapy [Cytotherapy] 2001; Vol. 3 (3), pp. 165-73.Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

Incidence of invasive fungal disease after unmanipulated haploidentical stem cell transplantation was significantly higher than that after HLA-matched sibling transplantation.

  • Authors : Sun Y; Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Diseases, Beijing, China.; Xu L

Subjects: Tissue Donors*; Graft vs Host Disease/Graft vs Host Disease/Graft vs Host Disease/*complications ; Hematopoietic Stem Cell Transplantation/Hematopoietic Stem Cell Transplantation/Hematopoietic Stem Cell Transplantation/*adverse effects

  • Source: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2013 Nov; Vol. 19 (11), pp.Publisher: Elsevier Country of Publication: England NLM ID: 9516420 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Mesenchymal stromal cells inhibit graft-versus-host disease of mice in a dose-dependent manner.

  • Authors : Joo SY; Department of Microbiology, Ewha Womans University School of Medicine, Ewha Medical Research Center, Seoul, Korea.; Cho KA

Subjects: Mesenchymal Stem Cell Transplantation*; Graft vs Host Disease/Graft vs Host Disease/Graft vs Host Disease/*prevention & control ; Hematopoietic Stem Cell Transplantation/Hematopoietic Stem Cell Transplantation/Hematopoietic Stem Cell Transplantation/*adverse effects

  • Source: Cytotherapy [Cytotherapy] 2010 May; Vol. 12 (3), pp. 361-70.Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults.

Subjects: Remission Induction*; Graft vs Host Disease/Graft vs Host Disease/Graft vs Host Disease/*immunology ; Hematologic Neoplasms/Hematologic Neoplasms/Hematologic Neoplasms/*therapy

  • Source: Cytotherapy [Cytotherapy] 2009; Vol. 11 (3), pp. 278-88.Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Haemopoietic stem-cell transplantation: improving immune reconstitution, avoiding graft-versus-host disease.

  • Authors : Dickinson A; University Department of Haematology, Royal Victoria Infirmary, Newcastle upon Tyne NEI 4LP, UK. ; Cant A

Subjects: Graft vs Host Disease/Graft vs Host Disease/Graft vs Host Disease/*prevention & control ; Hematopoietic Stem Cell Transplantation/Hematopoietic Stem Cell Transplantation/Hematopoietic Stem Cell Transplantation/*methods; Graft vs Host Disease/Graft vs Host Disease/Graft vs Host Disease/immunology

  • Source: Lancet (London, England) [Lancet] 2002 Jul 13; Vol. 360 (9327), pp. 98-9.Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Print

Record details

×
Editorial & Opinion

Survival after bone-marrow transplantation.

Subjects: Bone Marrow Transplantation* ; Cytomegalovirus*; Graft vs Host Disease/Graft vs Host Disease/Graft vs Host Disease/*prevention & control

  • Source: Lancet (London, England) [Lancet] 2002 Mar 09; Vol. 359 (9309), pp. 888.Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

Optimized clinical-scale culture conditions for ex vivo selective depletion of host-reactive donor lymphocytes: a strategy for GvHD prophylaxis in allogeneic PBSC transplantation.

  • Authors : Solomon SR; Stem Cell Allotransplantation Section, Hematology Branch, NHLBI, National Institutes of Health, Bethesda, MD 20892-1652, USA.; Tran T

Subjects: Lymphocyte Depletion*; Cell Culture Techniques/Cell Culture Techniques/Cell Culture Techniques/*methods ; Graft vs Host Disease/Graft vs Host Disease/Graft vs Host Disease/*prevention & control

  • Source: Cytotherapy [Cytotherapy] 2002; Vol. 4 (5), pp. 395-406.Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

Pharmacokinetics of CAMPATH-1H in BMT patients.

Subjects: Antigens, Neoplasm*; Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*pharmacokinetics ; Bone Marrow Purging/Bone Marrow Purging/Bone Marrow Purging/*methods

  • Source: Cytotherapy [Cytotherapy] 2001; Vol. 3 (4), pp. 261-7.Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

Mismatched transplants for refractory lymphoma?

Subjects: Bone Marrow Transplantation*; Graft vs Host Disease/Graft vs Host Disease/Graft vs Host Disease/*prevention & control ; Lymphoma, Non-Hodgkin/Lymphoma, Non-Hodgkin/Lymphoma, Non-Hodgkin/*therapy

  • Source: Lancet (London, England) [Lancet] 1999 May 22; Vol. 353 (9166), pp. 1725-6.Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

Improving clinical outcomes using adoptively transferred immune cells from umbilical cord blood.

  • Authors : Hanley PJ; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas 77030, USA.; Cruz CR

Subjects: Cord Blood Stem Cell Transplantation*/Cord Blood Stem Cell Transplantation*/Cord Blood Stem Cell Transplantation*/adverse effects ; Immunotherapy, Adoptive* ; Transplantation Conditioning*/Transplantation Conditioning*/Transplantation Conditioning*/adverse effects

  • Source: Cytotherapy [Cytotherapy] 2010 Oct; Vol. 12 (6), pp. 713-20.Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print Cited Medium: Internet

Record details

×
  • 1-22 of  22 results for ""Hematopoietic Stem Cell Transplantation""